Article in Vaccines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors.
Huiling WangShanghai Public Health Clinical Center & Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, 2901 Cao Lang Road, Jinshan District, Shanghai 201508, China.ORCID 0009-0003-4507-7212
Shiqi XieShanghai Public Health Clinical Center & Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, 2901 Cao Lang Road, Jinshan District, Shanghai 201508, China.
Shaoqiong HuangShanghai Public Health Clinical Center & Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, 2901 Cao Lang Road, Jinshan District, Shanghai 201508, China.
Xuejiao HuangShanghai Public Health Clinical Center & Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, 2901 Cao Lang Road, Jinshan District, Shanghai 201508, China.
Ying ZhangShanghai Public Health Clinical Center & Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, 2901 Cao Lang Road, Jinshan District, Shanghai 201508, China.
Juan WuShanghai Public Health Clinical Center & Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, 2901 Cao Lang Road, Jinshan District, Shanghai 201508, China.
Xiao-Yong FanShanghai Public Health Clinical Center & Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, 2901 Cao Lang Road, Jinshan District, Shanghai 201508, China.ORCID 0000-0001-6654-3559
Zhidong HuShanghai Public Health Clinical Center & Shanghai Institute of Infectious Diseases and Biosecurity, Fudan University, 2901 Cao Lang Road, Jinshan District, Shanghai 201508, China.ORCID 0000-0001-8490-4389
Funding
National Key Science and Technology Project for Prevention and Control of Emerging and Major Infectious Diseases of China 2025ZD01904000National Key Science and Technology Project for Prevention and Control of Emerging and Major Infectious Diseases of China 2025ZD01907500National Natural Science Foundation of China 32394014National Natural Science Foundation of China 32470998Shanghai Disease Control and Prevention Administration 2024GKM34Shanghai Municipal Health Commission 2022XD060Shanghai Municipal Health Commission 2024ZZ2009Shanghai Oriental Talent Youth Program QNWS2024033
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
dendritic cellspolyfunctional T cellstrained immunitytuberculosisvaccine
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Mucosal Adenovirus-Vectored Rv2299c Vaccine Protects Against Tuberculosis by Inducing Trained Immunity in Dendritic Cells and Polyfunctional T Cells. · full record | OpenQuestion